# Lycera Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lycera

- Industry: Pharmaceuticals
- Headquarters: Plymouth, US
- Website: www.lycera.com
- Total disclosed funding: $47M
- Latest round: Series A (Apr 28, 2010)
- Investors on record: 4

## About

Lycera Corporation is based in US and operates as a biopharmaceutical company which engages in discovery and development of novel oral medicines for treating autoimmune diseases.

## Funding rounds

- Series A, Apr 28, 2010, $11M — ARCH Venture Partners, InterWest Partners, EDF Ventures, Clarus Ventures
- Series A, Apr 16, 2009, $36M — ARCH Venture Partners, InterWest Partners, EDF Ventures, Clarus Ventures
- Seed, Nov 1, 2006 — EDF Ventures

## Investors

- EDF Ventures (https://capitalatlas.ai/funds/edf-ventures) — Seed, Series A
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A
- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series A